A crude enzyme preparation from a nadA mutant of Escherichia coli was used to catalyze the conversion of ['4C]aspartic acid into a precursor of quinolinic acid, a key intermediate in the biosynthesis of nicotinamide adenine dinucleotide.
The biosynthetic pathway leading to the formation of nicotinamide adenine dinucleotide (NAD) in Escherichia coli remains undefined. A defect in either one of two genetic loci (nadA, nadB) prevents the formation of quinolinic acid (QA), a key intermediate in the biosynthesis of NAD, from the known substrates aspartic acid and dihydroxyacetone phosphate (6) . The nadA-coded enzyme precedes the nadB-coded enzyme in the pathway (5) . The presence of these two enzymes argues for at least one intermediate in the formation of QA. Energetic considerations of the reactions argue in favor of more than one intermediate. For QA to be synthesized, two covalent bonds must be formed between aspartic acid (or a metabolite of aspartic acid) and dihydroxyacetone phosphate for ring closure, carbonyl reduction must occur, and three double bonds must be introduced into the ring structure (2) . Because of the number of reactions that must occur, it is feasible to assume that multiple enzymes are required and a multiplicity of intermnediates is formed.
In this paper we report the synthesis of a QA precursor from aspartic acid by a cell-free extract of a nadA mutant of E. coli. The presence of this compound supports the hypothesis that there is more than a single enzymatic step in the synthesis of QA from aspartic acid and dihydroxyacetone phosphate. Furthermore, we present definitive evidence that aspartic acid is modified before it condenses with dihydroxyacetone phosphate.
All bacterial strains were derivatives of E. coli K-12. Strain UTH4556 is a nadA auxotroph which also requires proline and histidine for growth. Strain UTH7042 is a nadC auxotroph.
The minimal medium of Davis and Mingioli (4) to which thiamine (2 mg/liter) and nicotinic acid (1.6 mM) were added was the basic growth medium. The repression medium contained 5 mM nicotinic acid but otherwise was the same as the standard growth medium. For the cultivation of strain UTH4556, the medium was additionally supplemented with 100 mg of histidine and 20 mg of proline per liter. The cell lines were carried on the appropriate minimal medium which had been solidified with 1.5% agar.
In a typical experiment, inoculum from the agar was added to 300 ml of minimal medium contained in a 1-liter flask. The medium was then incubated at 370C with vigorous aeration on a New Brunswick reciprocal shaker for 24 h. At this point the cells were harvested by centrifugation in an Intemational B-20A refrigerated centrifuge at 40C for 10 min at a force of 7,500 x g. The supematant was discarded, and the resulting pellet was suspended in a volume of 0.9% NaCl equal to four times the weight of the cells. This suspension was recentrifuged as previously described. The saline supematant was decanted, and the resulting pellet was immediately frozen at -68°C.
Frozen cells for in vitro experiments were partially thawed at ambient temperature and then suspended in a volume of 0.05 M phosphate buffer at pH 8.0 (7. A cell-free extract of a nadA mutant was used to catalyze the conversion of aspartic acid into presumed precursors of QA. These metabolites were then subjected to separation by ion-exchange chromatography. The resulting profile of radioactivity is illustrated in Elution profile of radiolabeled compounds synthesized by a nadA mutant of E. coli. Before chromatography the sample was prepared by precipitating the protein from the in vitro reaction mixture with 0.3 ml of 1.5 N perchloric acid. The mixture was then centrifuged for 10 min at 7,500 x g, and the precipitate was discarded. The perchloric acid was in turn precipitated by the addition of 0.2 ml of 2.5 N KOH. The mixture was again centrifuged for 10 min at 7,500 x g, and the precipitate was discarded. The pH of the supernatant was adjusted to neutrality with 4 N acetic acid. A 1-ml portion of this preparation was then subjected to anion-exchange chromatography. The anion exchange resin was Dowex-1-chloride X-8. The resin was prepared for chromatography by the method of Cooper (3) with a slight modification; the resin was washed with 0.1 M ammonium acetate starting buffer until pH stability, instead of water as in the method of Cooper. The prepared resin was packed in a 1-cm-diameter column to a height of 20 cm. The sample was layered on the column, and the column was washed with 30 ml of 0.1 M ammonium acetate. An ammonium acetate gradient was then applied (0.1 to 1.5 M) by using 18 ml of each ammonium acetate concentration.
After the gradient, the column was successively washed with 30 ml of2 N acetic acid and 40 ml of2 N HCl to remove any tightly bound materials that would not elute with the gradient. Samples of3 ml were collected of all of the column washings. These samples were then analyzed for radioactivity by liquid scintillation spectrophotometry. A fraction of 100 Itl was taken from each tube andplaced in a scintillation vial containing 7.5 ml of scintillation fluid. The scintillation fluid contained (per liter): 600 ml of toluene, 400 ml of 95% ethanol, 4 (Fig. lb) . Under repressed conditions only peak G disappears from the profile of radioactive materials.
Early intermediates in the QA biosynthetic pathway might be expected to incorporate label from a single source, either aspartic acid or fructose-1,6-diphosphate, whereas more immediate precursors of QA would be expected to incorporate label from both sources. Since the available evidence indicates that the nadA gene codes for an enzyme in the early part of the pathway, it was presumed that the nadA mutant was blocked at an initial step in the synthesis of QA. If this were so, then the material in peak G would not necessarily be expected to incorporate label from fructose-1,6-diphosphate (as a source of dihydroxyacetone phosphate). Figure lc and d indicate that the nadA mutant does not incorporate label from fructose-1,6-diphosphate into peak G. To rule out the trivial explanation that the nadA mutant lacked the ability to convert fructose-1,6-diphosphate into dihydroxyacetone phosphate, it was demonstrated that the crude enzyme preparation from the nadA mutant and commercially acquired aldolase exhibited identical enzymatic activity toward fructose-1,6-diphosphate, i.e., the enzymatic products were the same.
The definitive proof that peak G contains a precursor of QA is the evidence that the material can be converted to QA. Peak G was subjected to fractionation by several chromatographic procedures, and in all cases it migrated as a single peak. The reverse-phase column, and a solvent of 0.005 M tetrabutyl ammonium phosphate (pH 7.5). Therefore, peak G represented a relatively pure substance. This material was used as the substrate for the QA-biosynthetic enzymes in a nadC mutant. The nadC genetic block occurs after the synthesis of QA and prevents the conversion of QA into nicotinic acid mononucleotide; QA accumulates in these mutants. In this system, QA was synthesized from the peak G material (Table 1) . Furthermore, this conversion occurred at a more rapid rate than the synthesis of QA from aspartate.
The metabolite which we have isolated appears to be an early intermediate in the biosynthesis of QA. This finding supports the hypothesis of Wicks et al. (7) 
